Axsome Therapeutics Inc. (AXSM) Stock: Better Than You Think
Axsome Therapeutics Inc. (NASDAQ: AXSM) received FDA clearance for its neurological candidate last week, causing the company’s stock to rise by more than 60% in a few days. On August 26, the AXSM share was valued $67.13 in trade. Previously, Ffin.Ru discussed the intriguing development of Axsome Therapeutics Inc. (AXSM) named AXS-05, which is now […]
